Meet the Editors
The development of genome engineering technology based on the prokaryotic CRISPR-Cas adaptive immune systems is one of the most powerful biological breakthroughs in recent decades. It enables precise genetic changes in a wide variety of organisms, has transformed basic research, and holds tremendous promise in biotechnology and medicine.
The roster of editing proteins continues to expand as meganucleases, zinc finger nucleases, transcription activator-like effectors, and Cas9 proteins from the class 2 bacterial CRISPR system have all been successfully engineered to modify target DNA sequences in eukaryotic systems. Of these, the RNA-guided DNA endonuclease Cas9 has become the most widely used because of its simplicity, efficiency, and scalability. However, CRISPR-Cas9 editors are not without their limitations. Fortunately, remarkable advances have been made to optimize Cas9 to improve flexibility, fidelity, and precision.
Initial CRISPR-Cas genome editing largely relied on Streptococcus pyogenes Cas9 (SpCas9), but its relatively large size hinders viral delivery and cellular expression. Two smaller Cas9 orthologs from Staphylococcus aureus and Streptococcus thermophilus have since been engineered to achieve efficient genome editing in eukaryotic systems (Kleinstiver et al., 2015; Ran et al., 2015) . SpCas9 targets require the presence of a specific nearby sequence, the protospacer adjacent motif (PAM), which can also limit its utility. Engineered SpCas9 variants that recognize alternative PAM sequences have been developed, broadening its targeting range (Kleinstiver et al., 2015) .
Another critical aspect of improving CRISPR-Cas genome editing, particularly for clinical applications, is the reduction of off-target effects. Multiple strategies to enhance Cas9 specificity have been reported. Most notably, groups led by Feng Zhang and Keith Joung have shown that rational engineering of Cas9 by structure-guided amino acid substitutions to reduce the strength of non-specific interactions with DNA can significantly improve its specificity while maintaining robust activity (Kleinstiver et al., 2016; Slaymaker et al., 2016) .
Perhaps the biggest challenge to genome editing, however, is the relatively low efficiency of precisely replacing DNA sequences. Resolution of a Cas9-mediated doublestranded DNA break (DSB) to insert new designer sequence would ideally involve homology-directed repair (HDR). However, this repair pathway is utilized only infrequently with the error-prone non-homologous end joining (NHEJ) predominating. The resulting sequence often contains insertions or deletions (indels). Exacerbating this problem, if a genomic site is replaced by HDR, it can be subjected to re-cutting by Cas9, leading to unwanted indels. One possible workaround for this latter issue is to design the donor template such that the replacement locus contains mutations in the PAM sequence or guide RNA targeting sequence to block secondary cutting. However, unlike mutations that are intended to be introduced through HDR, these ''blocking mutations'' leave ''scars'' on the genome that could have unintended consequences. Marc Tessier-Lavigne and colleagues developed CORRECT, a multi-step procedure, to remove these blocking mutations and achieve scarless genome editing; they also devised methods to enable more straightforward introduction of heterozygous mutations in cells (Paquet et al., 2016) .
Tackling editing inefficiency in a different way, David Liu and his colleagues introduced an innovative strategy that circumvents the need for inherently inefficient HDR altogether and instead relies on base editing (Komor et al., 2016) . In this system, catalytically inactive Cas9 fused with a cytidine deaminase APOBEC1, termed base editor, effectively mediates direct base conversion of cytidine to uridine at the desired genomic locations. They showed that conjugating a base editor with a uracil glycosylase inhibitor that impedes base excision repair on the edited strand, together with substituting catalytically inactive Cas9 of the base editor with Cas9 nickase that nicks and induces mismatch repair on the non-edited strand, further improves the editing efficiency. Taking advantage of endogenous DNA repair machineries, these sophisticated base editors successfully expand the scope of genome engineering.
Finally, recent progress in metagenomics, bioinformatics, and microbiology has enabled scientists to identify and characterize novel nucleases from different prokaryotic defense systems (Shmakov et al., 2015) . Engineering these newly discovered proteins to function in eukaryotic systems has greatly diversified the genome-editing toolbox. One such enzyme is Cpf1, a single RNA-guided DNA endonuclease from the class 2 CRISPR system that utilizes a short T-rich PAM and introduces a staggered DSB, offering several advantages over Cas9 (Fonfara et al., 2016; Zetsche et al., 2015) . Natronobacterium gregoryi Argonaute (NgAgo) also has substantially different properties from Cas9. It depends on a single-stranded DNA as the guide to target and cleave the genome, a process that does not require a PAM, allowing editing of GC-rich regions .
While the prospect of genome editing has fired the imagination of researchers in almost every field, some experiments have been hampered by the lack of effective tools. Now, by improving Cas9 and reprogramming novel enzymes, researchers can access a host of tools suitable for diverse genome-editing applications and accelerate their movement toward the clinic as therapeutics. If you haven't already, meet the new editors.
